Home > Income Statement > VALIANT LABORATORIES

VALIANT LABORATORIES
Revenue

    Back to Income Statement
VALIANT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Sales ₹237 Cr₹133 Cr₹182 Cr₹334 Cr

What is the latest Revenue of VALIANT LABORATORIES ?

The latest Revenue ratio of VALIANT LABORATORIES is ₹237 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹237 Cr
Mar2025₹133 Cr
Mar2024₹182 Cr
Mar2023₹334 Cr

How is Revenue of VALIANT LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹237 Cr
78.04
Mar2025 ₹133 Cr
-26.74
Mar2024 ₹182 Cr
-45.48
Mar2023 ₹334 Cr -

Compare Revenue of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹560.6 Cr -7.7% -24.8% 24.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr 1.2% 9.1% 6.6% Stock Analytics
DIVIS LABORATORIES ₹296,741.0 Cr -2.7% 22.2% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1% 2% 20.8% Stock Analytics
DR REDDYS LABORATORIES ₹116,771.0 Cr 1.5% 13% 12.1% Stock Analytics
CIPLA ₹114,397.0 Cr 1.7% 7.8% -7.3% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-7.7%

-24.8%

24.4%

SENSEX

1.4%

12.4%

-1.7%


You may also like the below Video Courses